We are live on ! Find out more
ORTX

Orchard Therapeutics plc American Depositary Shares
ORTX

Delisted

ORTX was delisted on the 23rd of January, 2024.

Back to rankings

81 hedge funds and large institutions have $895M invested in Orchard Therapeutics plc American Depositary Shares in 2019 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 26 increasing their positions, 17 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

190% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 10

53% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 17

31% more funds holding

Funds holding: 62 → 81 (+19)

18% more capital invested

Capital invested by funds: $755M → $895M (+$139M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
81
Holders Change
+19
Holders Change %
+30.65%
% of All Funds
1.6%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
29
Increased
26
Reduced
17
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$27.7M
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$22.1M
3
JP Morgan Chase
JP Morgan Chase
New York
+$17.8M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$14.6M
5
RCM
RA Capital Management
Massachusetts
+$14.2M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$98.9M
2
PI
Putnam Investments
Massachusetts
-$11.8M
3
FCMI
Foresite Capital Management IV
California
-$6.63M
4
PA
Perceptive Advisors
New York
-$6.2M
5
CAM
Cormorant Asset Management
Massachusetts
-$3.95M
Name Holding Trade Value Shares
Change 		Change in
Stake
SI
26
Sofinnova Investments
California
$3.9M – – –
EAM
27
Eventide Asset Management
Massachusetts
$3.71M – – –
GTC
28
Ghost Tree Capital
New York
$3.08M -$226K -1,859 -8%
JPC
29
Jabodon PT Co
Nevada
$2.99M +$893K +7,341 +51%
BCP
30
Berylson Capital Partners
Massachusetts
$2.85M +$1.04M +8,585 +71%
AA
31
ALPS Advisors
Colorado
$2.63M +$23.3K +192 +1%
Arrowstreet Capital
32
Arrowstreet Capital
Massachusetts
$2.17M -$186K -1,528 -9%
N
33
Nuveen
North Carolina
$2.15M -$30K -247 -2%
Marshall Wace
34
Marshall Wace
United Kingdom
$1.91M +$1.35M +11,071 +394%
Victory Capital Management
35
Victory Capital Management
Texas
$1.88M – – –
Bank of America
36
Bank of America
North Carolina
$1.77M -$153K -1,257 -9%
TD Asset Management
37
TD Asset Management
Ontario, Canada
$1.63M +$140K +1,150 +11%
WP
38
Woodline Partners
California
$1.55M +$1.37M +11,276 New
Canada Pension Plan Investment Board
39
Canada Pension Plan Investment Board
Ontario, Canada
$1.45M +$1.28M +10,517 New
PPA
40
Parametric Portfolio Associates
Washington
$1.15M +$219K +1,801 +27%
MOACM
41
Mutual of America Capital Management
New York
$1.11M +$980K +8,060 New
Millennium Management
42
Millennium Management
New York
$1.07M -$3.71M -30,548 -80%
PAWC
43
P.A.W. Capital
Connecticut
$963K +$851K +7,000 New
State Street
44
State Street
Massachusetts
$559K +$99.1K +815 +25%
OAM
45
Oxford Asset Management
United Kingdom
$557K +$61.4K +505 +14%
Neuberger Berman Group
46
Neuberger Berman Group
New York
$550K +$486K +4,000 New
Northern Trust
47
Northern Trust
Illinois
$544K -$2.8K -23 -0.6%
Verition Fund Management
48
Verition Fund Management
Connecticut
$543K +$480K +3,948 New
MC
49
Matisse Capital
Oregon
$509K +$450K +3,700 New
WCM
50
Weld Capital Management
New York
$460K +$407K +3,346 New
1
2
3 4

ORTX Hedge Fund Activity: Q4 2019 in Review

81 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q4 2019, worth a combined $895M — up 18% from $755M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new ORTX positions and 10 closed out — a net gain of 19 holders — while 26 added to existing stakes and 17 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $27.7M. The largest seller was Fidelity Investments, cutting an estimated $98.9M.

  • 81 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q4 2019, up from 62 in Q3 2019.
  • Funds reported $895M of Orchard Therapeutics plc American Depositary Shares stock for Q4 2019, up 18% quarter-over-quarter.
  • 29 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q4 2019 and 10 closed out, a net change of +19 holders.
  • The largest Orchard Therapeutics plc American Depositary Shares buyer in Q4 2019 was Wellington Management Group, an estimated $27.7M added.
  • The largest Orchard Therapeutics plc American Depositary Shares seller in Q4 2019 was Fidelity Investments, an estimated $98.9M sold.

Based on aggregated 13F filings for Q4 2019.